Table 1.

Patient characteristics and outcomes

Characteristics	Outcomes
Patient characteristics
Age (median, range)	63 (46-74)
Male (%)	13 (76%)
Spleen size reduction
Treatment reduction (median, range)	7.3% (0%-22.5%)
Long-term reduction (median, range)	14.3% (-5.3%-36.5%)
Hematologic toxicities
Change in platelet count (/µL) (median, range)	-19,000 (-108,000-31,000)
Change in leukocyte count (/µL) (median, range)	-6350 (-27,900-1600)
Change in hemoglobin (g/dL) (median, range)	-0.4 (-1.9-0.9)
Transplant outcomes
Engraftment rate	100%
Median survival	4 years
Survival at time of review	82.4%